India · 
Who invested in Covacsis?
Covacsis's investors include Blume Ventures, Cisco and Gennext Ventures.
20132014
$450KSeries A?Series BIndia · Series B startup
Who invested in Covacsis
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$450Kraised across 2 rounds since 2012, from 2 sources
- Latest round
- Series BMay 2014
- Biggest round
- $450KSeries A · Sept 2012
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $450K Sept 2012
- Biggest round
- $450K Series A · Sept 2012
- Between rounds
- 20 months from the last two
The rounds
- May 2014Series BAmount undisclosed2 new1 returning
From a historical funding record
- Sept 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Covacsis as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Covacsis
How much has Covacsis raised?
Covacsis has raised $450K across 2 rounds since 2012. One round did not disclose an amount, so the total is a floor.
When did Covacsis last raise?
Covacsis's most recent round was a Series B in May 2014.
What was Covacsis's biggest round?
Covacsis's largest round on record is $450K (Series A), in Sept 2012.
Who backed Covacsis first?
Covacsis's first round on record, in Sept 2012, was backed by Blume Ventures.
What stage is Covacsis at?
Covacsis's latest named round is a Series B, in May 2014.
Where is Covacsis based?
Covacsis is based in India.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.